Source link : https://newshealth.biz/health-news/oral-glp-1-orforglipron-performs-well-in-phase-3-t2d-trials/
Phase 3 trials of the oral nonpeptide show glycemic and weight benefit when added to glargine and compared with dapagliflozin and oral semaglutide, but with somewhat lower tolerability. Medscape Medical News Source link : https://www.medscape.com/viewarticle/oral-glp-1-orforglipron-performs-well-phase-3-t2d-trials-2026a1000jfv?src=rss Author : Publish date : 2026-06-10 13:30:00 Copyright for syndicated content belongs to the linked Source.
The post Oral GLP-1 Orforglipron Performs Well in Phase 3 T2D Trials first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-10 13:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8